NCT06372925 - Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction | Biotech Hunter

Enrollment

318

Participants

Timeline

Start Date

July 12, 2024

Primary Completion Date

June 24, 2026

Study Completion Date

June 24, 2026

Conditions

Plaque, Atherosclerotic

Interventions

DRUG

atorvastatin

20mg atorvastatin PO

PROCEDURE

IVUS/OCT

performed the IVUS/OCT at baseline and Day 360

DRUG

inclisiran

Inclisiran 284mg SC

Trial Locations (19)

101149

RECRUITING

Novartis Investigative Site, Beijing

116000

RECRUITING

Novartis Investigative Site, Dalian

130033

RECRUITING

Novartis Investigative Site, Changchun

150086

RECRUITING

Novartis Investigative Site, Harbin

230001

RECRUITING

Novartis Investigative Site, Hefei

272000

RECRUITING

Novartis Investigative Site, Jining

300000

RECRUITING

Novartis Investigative Site, Tianjin

325027

RECRUITING

Novartis Investigative Site, Wenzhou

330006

RECRUITING

Novartis Investigative Site, Nanchang

350001

RECRUITING

Novartis Investigative Site, Fuzhou

430060

RECRUITING

Novartis Investigative Site, Wuhan

450052

RECRUITING

Novartis Investigative Site, Zhengzhou

510000

RECRUITING

Novartis Investigative Site, Guangzhou

510080

RECRUITING

Novartis Investigative Site, Guangzhou

518000

RECRUITING

Novartis Investigative Site, Shenzhen

563000

RECRUITING

Novartis Investigative Site, Zunyi

610072

RECRUITING

Novartis Investigative Site, Chengdu

710061

RECRUITING

Novartis Investigative Site, Xian

730000

RECRUITING

Novartis Investigative Site, Lanzhou